Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sebocyte lipogenesis refers to the complex biological process by which specialized epithelial cells in the sebaceous glands, known as sebocytes, synthesize and secrete sebum. Sebum is a unique mixture of lipids, including triglycerides, wax esters, and squalene, that is essential for maintaining the skin's moisture barrier and providing antimicrobial protection (Zouboulis et al., 2004, Journal of Investigative Dermatology). However, the dysregulation of this process—specifically the overproduction of sebum—is a primary driver in the pathogenesis of Acne vulgaris and seborrheic dermatitis (Makrantonaki et al., 2011, Dermato-endocrinology). Lipogenesis is tightly regulated by hormonal signals, particularly androgens acting through the androgen receptor, and metabolic enzymes such as acetyl-CoA carboxylase (ACC) and stearoyl-CoA desaturase (SCD) (Thiboutot, 2004, Journal of Investigative Dermatology). Therapeutic strategies targeting this pathway include systemic retinoids like isotretinoin, which reduce sebaceous gland size and activity by inducing sebocyte apoptosis, and topical agents like clascoterone that block androgenic stimulation (Hebert et al., 2020, JAMA Dermatology). While highly effective for dermatological conditions, the suppression of sebaceous activity often results in clinical challenges such as significant skin dryness and irritation due to the loss of protective surface lipids.
Inhibition of rate-limiting lipid biosynthesis enzymes (e.g., Acetyl-CoA carboxylase, Stearoyl-CoA desaturase 1), antagonism of the androgen receptor to reduce hormonal stimulation, or induction of sebocyte apoptosis and differentiation via retinoid signaling.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sebocyte lipogenesis.